Article Information

Nkosinathi Cele1*, Minenhle Mncube1, Rebamang Mosa3, Sthandiwe Mazibuko-Mbeje4,5, Thembeka Nyawo2,4, Khanyisani Ziqubu2,5, Sihle Mabhida2,6, Andy Opoku1

¹Department of Biochemistry and Microbiology, Department of Agriculture, University of Zululand, Private Bag X1001, KwaDlangezwa 3886, South Africa.

²Biomedical Research and innovation platform, South African Research Council, Tygerberg, 7505, South Africa.

³Department of Biochemistry Genetic and Microbiology, University of Pretoria, Private Bag X 20, Hatfield 0028, South Africa.

⁴Division of Medical Physiology, Faculty of Health Sciences, Stellenbosch University, Tygerberg 7505, South Africa.

⁵Department of Biochemistry, Faculty of Natural and Agricultural Sciences, North West University, Mafikeng Campus, Private Bag X 2046, Mmabatho 2735, South Africa.

⁶Department of Biotechnology, Faculty of Natural Science, University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa.

*Corresponding author: Nkosinathi Cele, Department of Biochemistry and Microbiology, Department of Agriculture, University of Zululand, Private Bag X1001, KwaDlangezwa 3886, South Africa.

Received: May 20, 2024;Accepted: May 29, 2024;Published: July 06, 2024

Citation: Nkosinathi Cele, Minenhle Mncube, Rebamang Mosa, Sthandiwe Mazibuko-Mbeje, Thembeka Nyawo2, Khanyisani Ziqubu, Sihle Mabhida, Andy Opoku. Methanolic Extract of Maytenus Procumbens Roots Ameliorates Erectile Dysfunction in Fructose-Streptozotocin Induced Type 2 Diabetes in Rats. Fortune Journal of Health Sciences. 7 (2024): 382-390.

Abstract

Keywords

Erectile dysfunction; Phosphodiesterase-5; cyclic guanosine monophosphate; Maytenus procumbens

Article Details

Introduction

Erectile dysfunction (ED), the most common form of sexual dysfunction in sexually active men, is defined as the repeated inability to attain and maintain an adequate erection for satisfactory sexual intercourse. ED results from the loss of penile vascular and smooth muscle relaxation due multiple pathophysiological conditions such hypogonadism, hypertension, type 2 diabetes mellitus (T2D), etc. [1]. Approximately, 90% of T2D men worldwide have been reported to have ED [2]. However, studies have shown that most clinicians do not enquire about sexual dysfunction during medical consultations and the prevalence of self-reported ED is also very low [3, 4].

The pathogenesis through which T2D induces ED result from multiple factors, such as increased formation of advanced glycation end products (AGEs), oxidative stress, deficiency in the nitric oxide-cyclic guanosine monophosphate (NO-cGMP) signaling pathway and hypogonadism [5, 6]. Among these factors, increased formation of AGEs is well-known to form covalent bonds with vascular collagen, causing a vascular thickening, reduced elasticity, endothelial dysfunction, increased vascular stiffness and subsequently results to ED [7]. Biomolecules such as testosterone, cGMP, NO, and acetylcholine (ACh) play a crucial role in penile erection processes [8]. For instance, the continuous decreased activity of nitric oxide synthase (NOS) which lead to a decreased NO production and depleted cGMP in the penile tissue and thus stimulate ED. Furthermore, literature also suggests that increased activities of acetylcholinesterase (AChE), arginase and angiotensin converting enzyme (ACE) are some causative agents of ED [9, 10]. Studies have shown that insulin enhance the expression of endothelial nitric oxide synthase (eNOS) and subsequently stimulate NO production [11, 12]. These actions of insulin are inhibited by the upregulation of RhoA, a small GTPase which stimulates Rho-kinase II (ROCK II) activity and directly inhibits expression of eNOS [13].

Furthermore, literature also suggests that increased activities of acetylcholinesterase (AChE), arginase and angiotensin converting enzyme (ACE) are some other contributing factors to the development of ED [10, 11].

Hence, in an attempt to ameliorate this medical condition (ED), there is currently a rapid increase in the number of men’s clinic. ED is currently treated with Sildenafil (Viagra) and Tadalafil (Cialis), which are all well known as PDE-5 inhibitors. However, these drugs are associated with adverse effects, and a large number of T2D men suffering from ED are refractory to these ED therapies [14]. Thus, the other approaches with less adverse effects could be employed in the discovery of new ED therapies, despite the broad research on ED therapy for many decades.

The use of medicinal plant extracts, due to their multi- target nature, continue to attract attention of researchers in a bid to discover new drug regime against various ailments, including ED. Maytenus procumbens (Celastraceae), which is predominantly in KwaZulu Natal, South Africa, is commonly used by Zulu traditional healers to treat several diseases linked to sexual dysfunction in men [15, 16]. The ameliorative effect of methanol roots extract of M. procumbens on butanol induced testicular dysfunction in Sprague Dawley rats has been reported [17]. The ameliorative effect was associated with the regeneration of spermatogonia in the seminiferous tubules, increased serum testosterone, sperm count and mount frequency of the rats. However, the molecular mechanism associated with this ameliorated sexual performance remains to be elucidated. Thus, this study investigated the methanolic extract of M. procumbens roots in type 2 diabetic induced erectile dysfunction in Sprague Dawley rats.

Materials and Methods

Chemicals and reagents

All chemicals and reagents used in this study were of analytical quality and all were purchased from Sigma-Aldrich Chemical Co., St. Louis, MO, USA.

Extract preparation

Maytenus procumbens roots were collected from Ndumo and confirmed by a qualified botanist at the Botany Department, University of Zululand, KwaZulu Natal, South Africa. The roots were thoroughly washed, chopped, air dried and ground into powder. The powdered plant material was extracted (1:5 w/v) with methanol to obtain methanolic crude extract. Thereafter, the methanolic extract was filtered through Whatman No. 1 filter paper. The methanol extract was then concentrated under reduced pressure at 40 °C using a rotary evaporator (Heidolph). The crude extract was then ready to be used for the biological assays.

Animals

Ethical clearance (UZREC 171110-030 PGD 2018/230) for approval of procedures and use of laboratory animals was obtained from the University of Zululand Research Ethics Committee (UZREC). Sprague-Dawley rats (06 - 12 weeks of age) were obtained from the laboratory animal unit of Biochemistry and Microbiology Department, University of Zululand. Rats were kept under standard laboratory conditions (at 23 ± 2 °C, 60% humidity and day-night cycle under light) as outlined in the institutional and national guidelines for handling and caring of science laboratory animals. The rats were allowed to acclimatize for at least five days with free access to enough normal rat feed and drinking water before the experiment commenced.

Induction of type 2 diabetes

Type 2 diabetes was induced using the method previously described by Pereira [18] with some modifications. Briefly, Sprague Dawley rats were randomly divided into two major groups; normal group (normal diet and drinking tap water) and high fructose fed group (normal diet and 25% of fructose in drinking water). The animals were put of high fructose for a period of 120 days. After 120 days, the high fructose fed group rats were fasted overnight and they were then given an intraperitoneal injection of a low single dose (30 mg/kg) of a freshly prepared streptozotocin (STZ) solution. After five days of the STZ injection, blood glucose levels were measured with a glucometer (Accutrend glucometer; Roche Diagnostics, Mannheim, Germany) from the blood collected from the tail tip. Animals with blood glucose levels equal to or above 09 mmol/l were considered diabetic and used in the study.

Investigation of the erectogenic effect of the plant extract

At the end of the induction of T2D, estrous was induced in a group of female rats (150 - 200 g). These female rats received three consecutive subcutaneous injections of progesterone (7.5 mg/kg, at 24-hour intervals) 96 hours before being introduced to male rats for determination of baseline sexual behavior of the male rats. After that, the normal group was subdivided into two groups while the diabetic group was also subdivided into four groups of five rats per group as shown in Figure 1.

Thereafter, the experimental groups were orally administered daily with the extract at 250 mg/kg b.w for 28 days. Normal control and negative control (Diabetic ED control) received a carrier solvent while positive controls received an indoor control RA-3 (100 mg/kg b.w) and Cialis (5 mg/kg b.w), respectively. Thereafter, estrous induced group of female rats (induced as described above), were then introduced to male rats for sexual animal behavior, each male rat from various treatment groups was individually subjected to the estrous female rats (n=3) in a separate cage for 30 minutes and the number of mounts was recorded.

Biochemical analysis

At the end of the experimental period, all the male rats were fasted for 8 hours and euthanized under anaesthesia. The loss of sensation was confirmed by the pedal withdrawal reflex and assessed by pinching of the tails, prior to blood collection. Blood was immediately collected by cardiac puncture and the penile tissues as well as brains were removed for analysis of significant biochemical assay. The collected blood was allowed to clot and centrifuged for 10 minutes at 3,500 rpm at 4 °C, and serum was collected. The brains were weighed and homogenized in 0.1 M phosphate buffer saline (pH 8.0). The serum levels of some antioxidants (SOD, CAT), MDA content, arginase and ACE activities as well as AChE activity from brain supernatant were estimated using respective commercial activity assay kits (Sigma- Aldrich), suitable for rat samples, following manufacturers’ instructions. The serum testosterone, and uric acid levels were determined using standard laboratory procedures (Global Laboratory & Viral Laboratory, Richards Bay).

Estimation of serum fructosamine concentration

Fructosamine concentration was determined in the serum of the rats using nitro-blue tetrazolium (NBT) assay as previously described by Adisakwattana [19]. Briefly, 125 µl of serum samples from the different groups was incubated with 125 µl of 0.5 mM NBT in 0.1 M sodium carbonate buffer (pH 10.4) at 37 °C for 15 minutes. The absorbance was measured at the wavelength of 590 nm. The concentration of fructosamine (mg/ml) in the respective samples was determined from the standard curve of 1-deoxy-1-morpholino-fructose (1-DMF).

Determination of protein thiol group

The Ellman’s assay was used to also determine the level of protein thiol groups [19]. The serum samples (125 µl) from different groups were incubated with 125 µl of 5 mM 5,5’-Dithiobis (2-nitrobenzoic acid, DTNB) solution for 15 minutes at 37 °C, followed by measuring the absorbance at the wavelength of 410 nm. The free thiol concentration of samples was calculated based on the standard curve prepared by using various concentration of L-cysteine.

Western blot analysis

Western blot analysis of some proteins involved in the erection process were performed. Snap frozen penile muscle tissue (100 mg) was defrosted on ice and lysed in lysis buffer (Pierce Biotechnologies, Rockford, CA, USA) using a Tissue lyser. Thereafter, the samples were centrifuged for 15 minutes at 13,000 rpm at 4 °C. Supernatant was collected and stored at -20 °C until required for use. Protein sample was mixed with an equal volume of 2x Laemmli sample buffer before it was denatured at 95 °C for 5 minutes. The denatured protein samples (30 μg) were loaded on the 12 % SDS-polyacrylamide gel (Bio-Rad, Hercules, CA, USA) and run for 1 hour at 150 V in Tris/Glycine/SDS-PAGE Buffer 1X. The proteins from the gel were then transferred to the polyvinylidene fluoride membrane (PVDF) (Bio-Rad, Hercules, CA, USA) (Johnson et al., 2017). The membranes (containing the proteins) were incubated at 4 °C for 16 hours with the following primary antibodies: anti- PDE-5 (1:500), RhoA (1:500) and eNOS (1:10000) (Sigma-Aldrich Chemical Co., St. Louis, MO, USA). The membranes were washed and incubated with the appropriate horseradish peroxidase conjugated secondary antibody at room temperature for 90 minutes. All proteins

Figure 1: Schematic representation of the erectogenic effect of the methanolic roots extract on type 2 diabetic rats.

were normalized to a loading control (β-Actin) (1:500) (Santa Cruz Biotechnology, Dallas, TX, USA). Chemidoc- XRS imager and image lab version 06 software (Bio-Rad Laboratories, Hercules, CA, USA) was used to Detect and quantify the proteins.

Statistical analysis

Results are presented as the mean ± standard error of the mean (mean ± SEM) in triplicates. Statistical analysis of the differences between mean values obtained from experimental groups were calculated using GraphPad prism (v6.01). Data were subjected to one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. p ≤ 0.05 was regarded as statistically significant.

Results

Fasting blood glucose (FBG), Mounting frequency and serum testosterone levels

Fasting blood glucose levels, mounting frequency and serum testosterone levels in diabetic induced ED rats after 28 days of treatment are shown in Table 1. The untreated diabetic ED rats presented with persistently higher fasting blood glucose levels. However, a slight decrease in the fasting blood glucose level, when compared to untreated diabetic ED group, was observed in diabetic ED rats treated with the extract for 28 days. Relatively lower testosterone levels, and mounting frequency when compared to the normal group, were also observed in untreated diabetic ED group. However, an increase (p< 0.001) in the tested parameters was evident in the animals treated with the extract.

Serum fructosamine, protein thiol group content and uric acid

Figure 2 shows the results of the effect of the extract on serum fructosamine, protein thiol group content and uric acid of the diabetic induced ED rats after 28 days of treatment. Elevated serum levels of fructosamine and lower protein thiol group were observed in the untreated diabetic animals or diabetic animals treated with Cialis, respectively, when compared to the normal control group. However, lower serum levels of the fructosamine content accompanied by a significant increase in protein thiol group concentrations were observed in the diabetic rats treated with the extract or RA-3 when compared to the untreated diabetic animals (Figure 2). Furthermore, a decreased uric acid level was also observed in the diabetic ED group treated with the extract or RA-3 when compared with an increase uric acid level in the untreated diabetic ED group.

Table 1: Effect of extract on FBG, mounting frequency and serum testosterone levels of the experimental rats

Results are expressed as the mean ± SEM, n = 5. Significantly at ***p<0.001 vs. Diabetic control.

Figure 2: Effect of the methanol extract on fructosamine (A); protein thiol (B) contents and uric acid levels (C). Results are expressed as the mean ± SEM, (n = 5). *p<0.01, ** p<0.001 vs. Untreated diabetic induced ED control. NC - Normal control, ND + Ext - Nondiabetic + extract, DED - diabetic ED control, DED + Cia - Diabetic + Cialis, DED + RA-3 - Diabetic ED + RA-3, DED + Ext - Diabetic ED + extract.

Effect of the extract on serum antioxidant status

Table 2 shows the results of the effect of the extract on some serum antioxidant levels in the diabetic induced ED rats. Significantly lower SOD and CAT levels along with a relatively higher MDA level were observed in the untreated diabetic ED group animals when compared to the normal control group. However, treatment of the diabetic rats with either extract or RA-3 displayed a significantly (p ≤ 0.001) increased SOD and CAT levels in comparison to the untreated diabetic-ED animals. This was accompanied by a significant (p ≤ 0.01) decrease in the MDA levels in extract or RA-3 treated groups.

Effect of the extract on the serum levels of ACE, AChE and arginase

The results of the effect of methanolic roots extract on ACE, AChE and arginase activities are presented in Figure

A significantly (p≤ 0.001) higher enzyme activities were observed in the untreated diabetic ED rats when compared with the normal control group. However, administration of the extract to the diabetic ED rats for 28 days, significantly (p≤ 0.001 and p≤ 0.0001) decreased the enzyme activities when compared to the untreated diabetic ED group.

Effect of the extract on the expression of PDE-5, RhoA and eNOS

Effect of the plant extract on the expression of some proteins involved in penile erection process was also investigated. The upregulation of PDE-5 (Figure 4A) and RhoA (Figure 4C) accompanied by down regulated eNOS (Figure 4B) were observed in untreated diabetic ED group when compared to normal rats. A significantly lower expression of PDE-5 and RhoA along with an increased expression of eNOS were observed in the penile tissues of the diabetic induced ED group

Table 2: Effects of methanol extract on serum antioxidants levels of the diabetic animals.

Results are expressed as the mean ± SEM, n = 5. Significantly at **p<0.01, ***p<0.001 vs. Diabetic control.

Figure 3: Effect of the methanol extract on ACE (A), arginase (B), and AChE (C) activities. Results are expressed as the mean ± SEM, (n = 5). Significant at ### p<0.001 vs. normal control, *** p<0.0001, and **p<0.001 vs. Untreated diabetic control. NC - Normal control, ND + Ext - Nondiabetic + extract, DED - untreated diabetic ED control, DED + Cia - Diabetic + Cialis, DED + RA-3 - Diabetic ED + RA-3, DED + Ext - Diabetic ED + extract.

Figure 4: Effect of the methanol extract on PDE-5 (A), eNOS (B) and RhoA (C) expression in type 2 diabetic rats. Values are expressed as the mean ± SD (n=4). ** p ≤ 0.01 vs. diabetic control, ### p ≤ 0.001 vs. diabetic control and normal control. NC - Normal control, ND + Ext - Nondiabetic + extract, DED - diabetic control, DED + Cia - Diabetic ED + Cialis, DED + RA-3 - Diabetic + RA-3, DED + Ext - Diabetic + extract.

treated with the extract. Furthermore, a significant decreased expression of PDE-5 and RhoA in the diabetic ED groups treated with RA-3 and Cialis observed was comparable to nondiabetic animals treated with extract.

Discussion

The increasing incidence of type 2 diabetes in men contributes to the increasing number of men with ED [1]. An increasing body of evidence supports the use of medicinal plants in the management of diabetic related complications including ED [20, 21]. In this study, the erectogenic effect of the methanolic extract from the roots of the M. procumbens in type 2 diabetic rats is reported.

The recorded elevated fasting blood glucose in the diabetic induced groups confirmed induction of diabetic state in the animals. While mounting behavior characterizes sexual provocation and penile orientation [1], testosterone regulates nearly every component of erectile function. In addition to increasing sexual desire, testosterone also stimulates synthesis of NO, which activates cascade of reactions leading to vasodilation in the penile tissue [22]. In the present study,the reduced mounting frequency and serum testosterone levels in the model diabetic ED rats indicated a decreased sexual desire/libido, a characteristic of ED. The observed increase in mounting frequency and testosterone levels following treatment of the diabetic rats with the extract indicated the erectogenic potential of the extract. In addition, augmented levels of testosterone and increased mounting frequency observed in the normal animals treated with extract further supported its erectogenic boosting ability.

The decreased serum levels of AChE, arginase and ACE in the extract treated groups further supported the erectogenic effect of the plant extract. Increased activities of AChE and arginase, commonly observed in diabetic state, diminishes the synthesis and bioavailability of NO, required for efficient penile erection process [23, 24]. Furthermore, the inhibitory effect of the extract on ACE activity, an enzyme that catalyzes the conversion of the angiotensin I to the active vasoconstrictor angiotensin II [25], indicates a potential to ameliorate hypertension-induced ED. Hence, the control of arginase, AChE and ACE have been reported as potential therapeutic strategy in the management or treatment of ED [26]. The enzymatic inhibitory activity exhibited by the extract could be attributed to the phytochemical composition of the plant, which includes saponins, tannins and alkaloids. These phytochemicals are known to inhibit the activities of arginase, AChE, ACE and PDE-5 [27-29].

The ability of the plant extract to lower the serum uric acid levels in the extract treated animals further supported its erectogenic potential. Uric acid, an end product of dietary and endogenous purine metabolism, modulate the physiological functions of various physical systems [30]. However, the link between serum uric acid level and ED is still controversial. Various reports have provided evidence that elevated uric acid level is a powerful scavenger of reactive oxygen species (ROS), thus acts as an antioxidant [31, 32]. Whereas other studies holding the opposite view have revealed that elevated level of uric acid is a potential risk factor of ED [33, 34]. In the current study we found that increased level of uric acid is associated with ED (Figure 2.C), hence, the lowered uric acid level observed on the extract treated rats could partly explain its erectogenic property.

Moreover, understanding the molecular mechanisms that underlie the development and progression of ED is also a vital objective in the management and treatment of the ailment. On one hand, PDE-5 hydrolyses cGMP, a second messenger molecule crucial for activating cascade of reactions leading to vasodilation in the penile tissue [35]. On the other hand, RhoA kinase pathway directly suppress the expression of eNOS, which leads to diminished eNOS activity and reduced bioavailability of NO, thus inhibiting the smooth muscle relaxation and erectile process [36]. The significant downregulation of PDE-5 and RhoA along with an increased expression of eNOS observed in the extract treated group provided support and an insight into the molecular basis of the erectogenic effect of the extract. Our results are similar to those reported by Corbin [24] and Bivalacqua et al [37], who showed the ability of the crude extracts to downregulate RhoA and increase eNOS expression and thus ameliorate erectile dysfunction in diabetic induced ED. Oboh and co- workers [27] have also shown that downregulation of PDE-5 ameliorates erectile dysfunction in diabetic rats .

The ability of the extract to also lower the fasting blood glucose levels (Table 1) and serum fructosamine (Figure 2A), a substance clinically used as a marker of short-term glycemic control in diabetic patients, demonstrated its antihyperglycemic property. The elevated blood glucose levels are known to promote AGEs formation, which accumulate in the corpus cavernosal tissue, particularly in the endothelial and smooth muscle cells, and contribute to the pathogenesis of diabetic ED [38, 39]. AGEs form covalent bonds with vascular collagen, which leads to vascular thickening, reduced elasticity, endothelial dysfunction and increased vascular stiffness [7]. The obtained results from the current work thus show that the crude extract and RA-3 (our in house hyperglycemia control compound [40, 41]) partly possesses a comparable hypoglycemic effect when compared to untreated diabetic ED rats and/or Cialis treated animals, respectively.

Chronic elevated blood glucose also induces oxidative stress which underlies various complications of diabetes including endothelial dysfunction and consequent ED development. Increased activity of SOD and CAT accompanied by decreased MDA levels (a measure of lipid peroxidation) in the extract treated diabetic ED group indicated the extract’s potential to enhance antioxidant defense system. The increased protein thiol group content in the extract treated diabetic rats (Figure 2B) further indicated the ability of the extract to enhance endogenous antioxidant status. Protein thiol groups are very vulnerable to oxidation and considered as one of the most valuable body sacrificial antioxidants [42]. The antioxidant property of the extract could play a crucial role in ameliorating diabetic induced erectile dysfunction incidence. Various plants with antioxidant properties have been reported to improve erectile function in diabetic-ED rats [26, 6, 29].

Conclusions

In conclusion, the present study provides evidence that methanolic roots extract of the Maytenus procumbens ameliorates diabetic induced erectile dysfunction, suggesting that the plant could potentially be used in the management of diabetic ED. The ameliorative effects of the extract were due to an increased testosterone levels and mount frequency accompanied by inhibitory effect on arginase, ACE and AChE activities in the diabetic ED treated group. In addition, the mechanism through which the extract exerts its erectogenic potential could be attributed to its ability to downregulate PDE-5 and RhoA accompanied by upregulated eNOS. Nevertheless, the effect of the extract on smooth muscle contraction and the histopathological analysis of the penile tissue from the diabetic induced ED in rats is recommended to confirm its erectogenic potential.

Acknowledgements

The authors are grateful the University of Zululand Research Committee team of for their technical assistance.

Contribution of authors

NDC analyzed the data; NDC, wrote the manuscript. ARO, RAM and SEM edited the manuscript. All authors read and approved the final manuscript.

Funding

Research reported in this review article was supported by the South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the Research Capacity Development Initiative from funding received from the South African National Treasury.

Availability of Data and Materials

All data generated or analyzed during this study are included in this article (however, supporting data are available from the corresponding author on reasonable request).

Conflict of interest:

No conflict of interest.

Ethics approval and consent to participate

Approval (Ethical Clearance Number: UZREC 171110- 030 PGM 2016/329) for use of laboratory animals (rats) and experimental procedures was granted by the University of Zululand research ethics committee (UZREC).

References

1. Minaz N, Razdan R, Hammock BD, Mujwar S, Goswamia Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor. Biomedicine and Pharmacotherapy 115 (2019): 108897.
2. Kaya E, Sikka SC, Gur S. A comprehensive review of metabolic syndrome affecting erectile dysfunction. The Journal of Sexual Medicine (2015): 856-875.
3. Kandeel FR, Koussa VK, Swerdloff RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation and treatment. Endocrine Reviews 22 (2001): 342-388.
4. Lozano I, Van der Werf R, Bietiger W, et al., High- fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular Nutrition and Metabolism 13 (2016).
5. Thakur M, Bhargava S and Dixit Effect of Asparagus racemosus on sexual dysfunction in hyperglycaemic male rats. Pharmaceutical Biology 47 (2008): 390-395.
6. Fu H, Bai X, Lee L, et Eucommia ulmoides Oliv. Leaf extract improves erectile dysfunction in streptozotocin- induced diabetic rats by protecting endothelial function and ameliorating hypothalamic-pituitary-gonadal axis function. Evidence-based Complementary and Alternative Medicine (2019).
7. Singh R, Barden A, Mori Advanced glycation end-products: a review. Diabetologia 44 (2001): 129-146.
8. Ademiluyi AO, Ogunsuyi OB, Adebayo AA and Oboh Effect of fermented legume seeds on some key enzymes relevant to erectile dysfunction in vitro. Journal of Food Biochemistry 42 (2018): e12437.
9. Tsai JE and Kass Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacology and Therapeutics 122 (2009): 216-238, 2009.
10. Shah N, Khurana S, Cheng K and Raufman Muscarinic receptors and ligands in cancer. American Journal of Physiology Cell Physiology 296 (2009): 221-232.
11. Zeng G and Quon Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. Journal of Clinical Investigation 98 (1996): 894-898.
12. Muniyappa R, Lantorno M and Quon MJ. An integrated view of insulin resistance and endothelial dysfunction. Endocrinology and Metabolism Clinics of North America 37 (2008): 685-711.
13. Goswami SK, Pandre MK, Jamwal R et Screening for Rho-kinase 2 inhibitory potential of Indian medicinal plants used in management of erectile dysfunction. Journal of Ethnopharmacology 144 (2012): 483-489, 2012.
14. Kizilay F, Gali HE and Serefoglu Diabetes and sexuality. Sexual Medicine Reviews (2016).
15. Momtaz S, Hussein AA, Ostad SN, Abdollahi M and Lall
16. Growth inhibition and induction of apoptosis in human cancerous HeLa cells by Mytenus procumbens. Tehran Iran 2 (2012): 3-5.
17. Cele Effect of methanolic extract of Maytenus procumbens and Ozoroa paniculosa on testicular dysfunction. Theses submitted to University of Zululand (2017).
18. Cele ND, Sangweni NF, Mosa RA et Testicular dysfunction ameliorative effect of the methanolic roots extracts of Maytenus procumbens and Ozoroa paniculosa. Evidence-Based Complementary and Alternative Medicine (2017): 1-7.
19. Pereira CD, Severo M, Rafael L, Martins MJ and Neves
20. Effects of natural mineral-rich water consumption on the expression of sirtuin 1 and angiogenic factors in the erectile tissue of rats with fructose-induced metabolic syndrome. Asian Journal of Andrology 16 (2014): 631-638.
21. Adisakwattana, W. Sompong, A. Meeprom, S. Ngamukote and S. Yibchok-Anun. Cinnamic acid and its derivatives inhibit fructose-mediated protein glycation. International Journal Molecules and Science 13 (2012): 1778-89.
22. Adefegha SA, Oboh G, Okeke BM and Oyeleye Comparative effects of alkaloid extracts from Aframomum melegueta (alligator pepper) and Aframomum danielli (bastered melegueta) on enzymes relevant to erectile dysfunction. Journal of Dietary Supplements 14 (2017): 542-552.
23. Ademosun AO, Adebayo AA and Oboh G. Anogeissus leiocarpus attenuates paroxetine-induced erectile dysfunction in male rats via enhanced sexual behavior, nitric oxide level and antioxidant Biomedicine and Pharmacotherapy 111 (2019): 1029-1035.
24. Vudriko P, Baru MK, Kateregga J, James G and Ndukui Crude ethanolic leaf extracts of Citropsis articulata: a potential phytomedicine for treatment of male erectile dysfunction associated with testosterone deficiency. International Journal of Basic and Clinical Pharmacology (2013).
25. Corbin JD. Mechanisms of action of PDE5 inhibition in erectile dysfunction. International Journal of Impotence Research 16 (2004): 4-7.
26. Vargas VM, Torres D and Corona Cholinergic facilitation of erection and ejaculation in spinal cord- transected rats, International Journal of Impotence Research 16 (2004): 86-90, 2004.
27. John S and Schmieder Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Current Science Association 5 (2003): 199-207.
28. Akomolafe SA, Oyeleye SI, Olasehinde TA and Oboh
29. Phenolic characterization, antioxidant activities and inhibitory effects of Physalis angulata and Newbouldia laevis on enzymes linked to erectile dysfunction. International Journal of Food Properties 21 (2018): 645-654.
30. Oboh G, Ademiluyi AO, Ademosun AO, et al. Phenolic extract from Moringa oleifera leaves inhibits key enzymes linked to erectile dysfunction and oxidative stress in rats’ penile Hindawi Publishing Corporation Biochemistry Research International (2015): 1-8.
31. Odubanjo VO, Olasehinde TA, Oyeleye SI, Oboh G and Boligon AA. Seed extracts from Myristica fragrans (Nutmeg) and Moringa oleifera (Drumstick tree) inhibits enzymes relevant to erectile dysfunction and metal- induced oxidative damage in rats’ penile tissues. Journal of Food Biochemistry 42 (2015).
32. Ojo OA, Ojo AB, Oyinloye BE et Ocimum gratissimum Linn. Leaves reduce the key enzymes activities relevant to erectile dysfunction in isolated penile and testicular tissues of rats. BMC Complementary and Alternative Medicine 19 (2019): 71.
33. Gao F, Jiang B, Cang Z, et Serum uric acid is associated with erectile dysfunction: a population- based cross-sectional study in Chinese men. Scientific reports (2017): 1-7.
34. Waring WS, McKnight JA, Webb DJ and Maxwell SR. Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes 55 (2016): 3127-3132.
35. Fabbrini E, Serafini M, Colic BI, Hazen SL and Klein
36. Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes 63 (2014): 976-981.
37. Seidman SN and Roose SP. The relationship between depression and erectile dysfunction. Current Psychiatry Reports 2 (2000): 201-205.
38. Ghofrani HA, Osterloh IH and Grimminger F. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and Nature Reviews 5 (2006): 689- 702.
39. Chaudhari K, Khanzode S, Dakhale G, Saoji A. Clinical Correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder. Indian Journal Clinical Biochemistry 25 (2010): 77-81.
40. Chitaley K, Wingard CJ, Clinton WR et al. Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nature Medicine 7 (2001): 119-122.
41. Bivalacqua TJ, Champion HC, Usta MF et al. RhoA/ Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile Proceedings of the National Academy of Sciences of the United States of America 15 (2004): 9121-9126.
42. Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J and Hampel N. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 50 (1997): 1016-1026.
43. Sandireddy R, Yerra VG, Areti A, Komirishetty P and Kumar A. Neuro-inflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these International Journal of Endocrinology (2014): 1-11.
44. Mosa RA, Cele ND, Mabhida SE, et In vivo antihyperglycaemic activity of a lanosteryl triterpene from Protorhus longifolia. Molecules 20: 13374-13383.
45. Mabhida SE, Mosa RA, Penduka D, et al. A lanosteryl triterpene from Protorhus longifolia improves glucose tolerance and pancreatic beta cell ultrastructure in type 2 diabetic Molecules 22 (2017): 1252.
46. Smith PR and Thornalley Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. European Journal of Biochemistry 210 (1992): 729-39.